{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:40:00Z","timestamp":1784061600887,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304267"],"award-info":[{"award-number":["82304267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Medical Products Administration (NMPA) Key Laboratory for Quality Analysis of Chemical Drug Preparations","award":["ZJ-KF-2023-2"],"award-info":[{"award-number":["ZJ-KF-2023-2"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24142201000"],"award-info":[{"award-number":["24142201000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00204-025-04166-1","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T02:52:17Z","timestamp":1756003937000},"page":"4665-4676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quantitative genotoxicity assessment of N-nitrosodimethylamine in mice by error-corrected next-generation sequencing and DNA methylation quantification for toxicity threshold determination"],"prefix":"10.1007","volume":"99","author":[{"given":"Xinyue","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-7803","authenticated-orcid":false,"given":"Yang","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"issue":"7793","key":"4166_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ et al (2020) The repertoire of mutational signatures in human cancer. Nature 578(7793):94\u2013101. https:\/\/doi.org\/10.1038\/s41586-020-1943-3","journal-title":"Nature"},{"issue":"2","key":"4166_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcad015","volume":"5","author":"AL Armijo","year":"2023","unstructured":"Armijo AL, Thongararm P, Fedeles BI et al (2023) Molecular origins of mutational spectra produced by the environmental carcinogen N-nitrosodimethylamine and S(N)1 chemotherapeutic agents. NAR Cancer 5(2):zcad015. https:\/\/doi.org\/10.1093\/narcan\/zcad015","journal-title":"NAR Cancer"},{"key":"4166_CR3","doi-asserted-by":"crossref","unstructured":"Ashford AL, Nachmanson D, Wills JW et al (2025) Alignment between Duplex Sequencing and transgenic rodent mutation assay data in the assessment of in vivo NDMA-induced mutagenesis. BioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2025.04.29.651210v1. Accessed 15 July 2025","DOI":"10.1101\/2025.04.29.651210"},{"key":"4166_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/em.22582","author":"MA Beal","year":"2023","unstructured":"Beal MA, Chen G, Dearfield KL et al (2023) Interpretation of in vitro concentration-response data for risk assessment and regulatory decision-making: report from the 2022 IWGT quantitative analysis expert working group meeting. Environ Mol Mutagen. https:\/\/doi.org\/10.1002\/em.22582","journal-title":"Environ Mol Mutagen"},{"key":"4166_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105415","volume":"142","author":"JP Bercu","year":"2023","unstructured":"Bercu JP, Masuda-Herrera M, Trejo-Martin A et al (2023) Acceptable intakes (AIs) for 11 small-molecule N-nitrosamines (NAs). Regul Toxicol Pharmacol 142:105415. https:\/\/doi.org\/10.1016\/j.yrtph.2023.105415","journal-title":"Regul Toxicol Pharmacol"},{"issue":"11","key":"4166_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.dnarep.2004.05.004","volume":"3","author":"F Drabl\u00f8s","year":"2004","unstructured":"Drabl\u00f8s F, Feyzi E, Aas PA et al (2004) Alkylation damage in DNA and RNA\u2013repair mechanisms and medical significance. DNA Repair (Amst) 3(11):1389\u20131407. https:\/\/doi.org\/10.1016\/j.dnarep.2004.05.004","journal-title":"DNA Repair (Amst)"},{"key":"4166_CR7","unstructured":"EMA (2025) Nitrosamine impurities: guidance for marketing authorisation holders. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/pharmacovigilance-post-authorisation\/referral-procedures-human-medicines\/nitrosamine-impurities\/nitrosamine-impurities-guidance-marketing-authorisation-holders. Accessed 15 July 2025"},{"key":"4166_CR8","unstructured":"FDA (2018) FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-voluntary-recall-several-medicines-containing-valsartan-following-detection-impurity. Accessed 15 July 2025"},{"key":"4166_CR9","unstructured":"FDA (2023) Recommended Acceptable Intake Limits for Nitrosamine Drug Substance Related Impurities (NDSRIs) Guidance for Industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/recommended-acceptable-intake-limits-nitrosamine-drug-substance-related-impurities. Accessed 15 July 2025"},{"issue":"3","key":"4166_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jama.2021.9199","volume":"326","author":"J Florian","year":"2021","unstructured":"Florian J, Matta MK, DePalma R et al (2021) Effect of oral ranitidine on urinary excretion of N-nitrosodimethylamine (NDMA): a randomized clinical trial. JAMA 326(3):240\u2013249. https:\/\/doi.org\/10.1001\/jama.2021.9199","journal-title":"JAMA"},{"key":"4166_CR11","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.chemosphere.2018.07.098","volume":"210","author":"AJ Gushgari","year":"2018","unstructured":"Gushgari AJ, Halden RU (2018) Critical review of major sources of human exposure to N-nitrosamines. Chemosphere 210:1124\u20131136. https:\/\/doi.org\/10.1016\/j.chemosphere.2018.07.098","journal-title":"Chemosphere"},{"issue":"1","key":"4166_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/em.22338","volume":"61","author":"RH Heflich","year":"2020","unstructured":"Heflich RH, Johnson GE, Zeller A et al (2020) Mutation as a toxicological endpoint for regulatory decision-making. Environ Mol Mutagen 61(1):34\u201341. https:\/\/doi.org\/10.1002\/em.22338","journal-title":"Environ Mol Mutagen"},{"key":"4166_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.fct.2015.03.008","volume":"80","author":"SS Herrmann","year":"2015","unstructured":"Herrmann SS, Duedahl-Olesen L, Christensen T, Olesen PT, Granby K (2015) Dietary exposure to volatile and non-volatile N-nitrosamines from processed meat products in Denmark. Food Chem Toxicol 80:137\u2013143. https:\/\/doi.org\/10.1016\/j.fct.2015.03.008","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"4166_CR14","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1111\/risa.12070","volume":"33","author":"SE Hrudey","year":"2013","unstructured":"Hrudey SE, Bull RJ, Cotruvo JA, Paoli G, Wilson M (2013) Drinking water as a proportion of total human exposure to volatile N-nitrosamines. Risk Anal 33(12):2179\u20132208. https:\/\/doi.org\/10.1111\/risa.12070","journal-title":"Risk Anal"},{"key":"4166_CR15","unstructured":"ICH M7 Sub-group (2025) Addendum to ICH M7 on Risk Assessment and Control of N-Nitrosamine Impurities. https:\/\/database.ich.org\/sites\/default\/files\/ICH_M7SubGroup_Final_Concept_Paper_2024_0424.pdf. Accessed 15 July 2025"},{"key":"4166_CR16","unstructured":"ICH (2023) Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R2). https:\/\/database.ich.org\/sites\/default\/files\/ICH_M7%28R2%29_Guideline_Step4_2023_0216_0.pdf. Accessed 15 July 2025"},{"key":"4166_CR17","unstructured":"ICH (2024) Impurities: guideline for residual solvents Q3C(R9). https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q3C%28R9%29_Guideline_MinorRevision_2024_2024_Approved.pdf. Accessed 15 July 2025"},{"issue":"6","key":"4166_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/mutage\/gei054","volume":"20","author":"GJ Jenkins","year":"2005","unstructured":"Jenkins GJ, Doak SH, Johnson GE, Quick E, Waters EM, Parry JM (2005) Do dose\u2013response thresholds exist for genotoxic alkylating agents? Mutagenesis 20(6):389\u2013398. https:\/\/doi.org\/10.1093\/mutage\/gei054","journal-title":"Mutagenesis"},{"issue":"5","key":"4166_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/em.22446","volume":"62","author":"GE Johnson","year":"2021","unstructured":"Johnson GE, Dobo K, Gollapudi B et al (2021) Permitted daily exposure limits for noteworthy N-nitrosamines. Environ Mol Mutagen 62(5):293\u2013305. https:\/\/doi.org\/10.1002\/em.22446","journal-title":"Environ Mol Mutagen"},{"key":"4166_CR20","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/543531","volume":"2010","author":"N Kondo","year":"2010","unstructured":"Kondo N, Takahashi A, Ono K, Ohnishi T (2010) DNA damage induced by alkylating agents and repair pathways. J Nucleic Acids 2010:543531. https:\/\/doi.org\/10.4061\/2010\/543531","journal-title":"J Nucleic Acids"},{"key":"4166_CR21","doi-asserted-by":"publisher","unstructured":"Kucab JE, Zou X, Morganella S et al (2019) A Compendium of Mutational Signatures of Environmental Agents. Cell 177(4):821\u2013836 e16. https:\/\/doi.org\/10.1016\/j.cell.2019.03.001","DOI":"10.1016\/j.cell.2019.03.001"},{"key":"4166_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/19440049.2024.2398704","author":"HS Lee","year":"2024","unstructured":"Lee HS (2024) Dietary exposure assessment for volatile N-nitrosamines from food and beverages for the U.S. population. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. https:\/\/doi.org\/10.1080\/19440049.2024.2398704","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"key":"4166_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094559","author":"Y Li","year":"2022","unstructured":"Li Y, Hecht SS (2022) Metabolic activation and DNA interactions of carcinogenic N-nitrosamines to which humans are commonly exposed. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23094559","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4166_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/mutage\/geae001","volume":"39","author":"AM Lynch","year":"2024","unstructured":"Lynch AM, Howe J, Hildebrand D et al (2024) N-nitrosodimethylamine investigations in Muta\u2122Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulations. Mutagenesis 39(2):96\u2013118. https:\/\/doi.org\/10.1093\/mutage\/geae001","journal-title":"Mutagenesis"},{"key":"4166_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mrgentox.2014.09.011","volume":"783","author":"JT MacGregor","year":"2015","unstructured":"MacGregor JT, Fr\u00f6tschl R, White PA et al (2015) IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). Mutat Res Genet Toxicol Environ Mutagen 783:55\u201365. https:\/\/doi.org\/10.1016\/j.mrgentox.2014.09.011","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"3","key":"4166_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/d41573-023-00014-y","volume":"22","author":"F Marchetti","year":"2023","unstructured":"Marchetti F, Cardoso R, Chen CL et al (2023) Error-corrected next-generation sequencing to advance nonclinical genotoxicity and carcinogenicity testing. Nat Rev Drug Discov 22(3):165\u2013166. https:\/\/doi.org\/10.1038\/d41573-023-00014-y","journal-title":"Nat Rev Drug Discov"},{"key":"4166_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0065-227X(04)80106-0","volume":"38","author":"T Nohmi","year":"2004","unstructured":"Nohmi T, Masumura K (2004) Gpt delta transgenic mouse: a novel approach for molecular dissection of deletion mutations in vivo. Adv Biophys 38:97\u2013121","journal-title":"Adv Biophys"},{"key":"4166_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/em.22599","author":"BL Parsons","year":"2024","unstructured":"Parsons BL, Beal MA, Dearfield KL et al (2024) Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT). Environ Mol Mutagen. https:\/\/doi.org\/10.1002\/em.22599","journal-title":"Environ Mol Mutagen"},{"key":"4166_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2024.114498","volume":"186","author":"DJ Paustenbach","year":"2024","unstructured":"Paustenbach DJ, Brown SE, Heywood JJ, Donnell MT, Eaton DL (2024) Risk characterization of N-nitrosodimethylamine in pharmaceuticals. Food Chem Toxicol 186:114498. https:\/\/doi.org\/10.1016\/j.fct.2024.114498","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"4166_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1021\/tx200031q","volume":"24","author":"AE Pegg","year":"2011","unstructured":"Pegg AE (2011) Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools. Chem Res Toxicol 24(5):618\u2013639. https:\/\/doi.org\/10.1021\/tx200031q","journal-title":"Chem Res Toxicol"},{"issue":"5","key":"4166_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/carcin\/bgae018","volume":"45","author":"LA Peterson","year":"2024","unstructured":"Peterson LA, Stanfill SB, Hecht SS (2024) An update on the formation in tobacco, toxicity and carcinogenicity of N\u2019-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 45(5):275\u2013287. https:\/\/doi.org\/10.1093\/carcin\/bgae018","journal-title":"Carcinogenesis"},{"issue":"23 Pt 2","key":"4166_CR32","first-page":"6452","volume":"51","author":"R Peto","year":"1991","unstructured":"Peto R, Gray R, Brantom P, Grasso P (1991) Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res 51(23 Pt 2):6452\u20136469","journal-title":"Cancer Res"},{"issue":"1","key":"4166_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/em.22342","volume":"61","author":"JJ Salk","year":"2020","unstructured":"Salk JJ, Kennedy SR (2020) Next-generation genotoxicology: using modern sequencing technologies to assess somatic mutagenesis and cancer risk. Environ Mol Mutagen 61(1):135\u2013151. https:\/\/doi.org\/10.1002\/em.22342","journal-title":"Environ Mol Mutagen"},{"issue":"3","key":"4166_CR34","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2023.7884","volume":"21","author":"D Schrenk","year":"2023","unstructured":"Schrenk D, Bignami M, Bodin L et al (2023) Risk assessment of N-nitrosamines in food. EFSA J 21(3):e07884. https:\/\/doi.org\/10.2903\/j.efsa.2023.7884","journal-title":"EFSA J"},{"issue":"10","key":"4166_CR35","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s00204-023-03560-x","volume":"97","author":"JE Seo","year":"2023","unstructured":"Seo JE, Yu JZ, Xu H et al (2023) Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models. Arch Toxicol 97(10):2785\u20132798. https:\/\/doi.org\/10.1007\/s00204-023-03560-x","journal-title":"Arch Toxicol"},{"issue":"1","key":"4166_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/carcin\/bgp262","volume":"31","author":"N Shrivastav","year":"2010","unstructured":"Shrivastav N, Li D, Essigmann JM (2010) Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis 31(1):59\u201370. https:\/\/doi.org\/10.1093\/carcin\/bgp262","journal-title":"Carcinogenesis"},{"issue":"3","key":"4166_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/mutage\/get010","volume":"28","author":"K Taira","year":"2013","unstructured":"Taira K, Kaneto S, Nakano K et al (2013) Distinct pathways for repairing mutagenic lesions induced by methylating and ethylating agents. Mutagenesis 28(3):341\u2013350. https:\/\/doi.org\/10.1093\/mutage\/get010","journal-title":"Mutagenesis"},{"issue":"9","key":"4166_CR38","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1016\/j.xphs.2021.04.021","volume":"110","author":"B Tuesuwan","year":"2021","unstructured":"Tuesuwan B, Vongsutilers V (2021) Nitrosamine contamination in pharmaceuticals: threat, impact, and control. J Pharm Sci 110(9):3118\u20133128. https:\/\/doi.org\/10.1016\/j.xphs.2021.04.021","journal-title":"J Pharm Sci"},{"issue":"52","key":"4166_CR39","doi-asserted-by":"publisher","first-page":"33414","DOI":"10.1073\/pnas.2013724117","volume":"117","author":"CC Valentine 3rd","year":"2020","unstructured":"Valentine CC 3rd, Young RR, Fielden MR et al (2020) Direct quantification of in vivo mutagenesis and carcinogenesis using duplex sequencing. Proc Natl Acad Sci U S A 117(52):33414\u201333425. https:\/\/doi.org\/10.1073\/pnas.2013724117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4166_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/em.22351","volume":"61","author":"PA White","year":"2020","unstructured":"White PA, Long AS, Johnson GE (2020) Quantitative interpretation of genetic toxicity dose-response data for risk assessment and regulatory decision-making: current status and emerging priorities. Environ Mol Mutagen 61(1):66\u201383. https:\/\/doi.org\/10.1002\/em.22351","journal-title":"Environ Mol Mutagen"},{"issue":"10","key":"4166_CR41","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1007\/s00204-020-02832-0","volume":"94","author":"X You","year":"2020","unstructured":"You X, Thiruppathi S, Liu W et al (2020) Detection of genome-wide low-frequency mutations with paired-end and complementary consensus sequencing (PECC-Seq) revealed end-repair-derived artifacts as residual errors. Arch Toxicol 94(10):3475\u20133485. https:\/\/doi.org\/10.1007\/s00204-020-02832-0","journal-title":"Arch Toxicol"},{"key":"4166_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad909","author":"X You","year":"2023","unstructured":"You X, Cao Y, Suzuki T et al (2023) Genome-wide direct quantification of in vivo mutagenesis using high-accuracy paired-end and complementary consensus sequencing. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkad909","journal-title":"Nucleic Acids Res"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04166-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04166-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T23:47:12Z","timestamp":1759103232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04166-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4166"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04166-1","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript does not contain clinical studies or patient data. The animal experiments were carried out in accordance with Animal Research: Reporting in Vivo Experiments (ARRIVE) guidelines\u00a0and with the approval of Institutional Animal Care and Use Committee of Shenyang Pharmaceutical University, China (SYPU-IACUC-S2023-0413\u2013201) and Shanghai Jiao Tong University School of Medicine, China (A-2019\u2013013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}